Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Earnings Results
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 6 August 2026
What it is about
Rodman RenshawCorient Private WealthNews Ratings For Zentalis Pharmaceuticals DailyQube Research Technologies LtdAlgert GlobalZentalis Pharmaceuticals Company ProfileEarnings History For Zentalis PharmaceuticalsZentalis Pharmaceuticals Price PerformanceZentalis PharmaceuticalsInstitutional Trading Of Zentalis Pharmaceuticals
Who published it, and when
How it spread - 1 original report
Thu, 6 August 2026
1 report- themarketsdaily.com23:56first to report
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.59) EPS for the quarter, missing the consensus estimate of ($0.45) by ($0.14), FiscalAI reports. Zentalis Pharmaceuticals Price Performance Shares of Zentalis Pharmaceuticals stock traded up $0.05 during trading on Thursday, hitting $5.00. The stock had a trading […]